VISEN Pharmaceuticals (HKG:2561)

VISEN Pharmaceuticals Revenue

VISEN Pharmaceuticals had revenue of 34.81M CNY in the half year ending June 30, 2026, with 1,133.16% growth. This brings the company's total for the last twelve months to 34.06M, up 3,950.06% year-over-year. In the year 2025, VISEN Pharmaceuticals had annual revenue of 136.00K, down -95.10%. That makes VISEN Pharmaceuticals the 39,978th largest company in the world by revenue and 2,444th in Hong Kong.

• Revenue (ttm): 34.06M CNY
• Revenue Growth: +3,950.06%
• P/S Ratio: 38.72
• Revenue / Employee: 333.93K CNY
• Employees: 102
• Market Cap: 1.52B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	136.00K	-2.64M	-95.10%
Dec 31, 2024	2.78M	4.45M	-
Dec 31, 2023	-1.67M	629.00K	-
Dec 31, 2022	-2.30M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error